Selective beta 1 and beta 2 adrenoceptor blockade on epinephrine-induced arrhythmias in halothane anaesthetized dogs

Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie
Y HayashiI Yoshiya

Abstract

Beta 2 as well as beta 1 adrenoceptors have been recognized in the heart of vertebrates. They mediate a positive chronotropic action of catecholamines. We compared the effect of selective beta 1 and beta 2 adrenoceptor antagonists on the genesis of halothane-epinephrine arrhythmias in dogs. The arrhythmogenic dose (AD) of epinephrine was increased in the presence of l-metoprolol, a selective beta 1 antagonist (8.40 +/- 1.13 micrograms.kg-1 x min-1; mean +/- SEM), compared with control value (2.62 +/- 0.56) (P < 0.05). In contrast, ICI-118,551, a selective beta 2 antagonist, did not change the AD (2.36 +/- 0.43). Adding ICI-118,551 to l-metoprolol did not affect the AD of epinephrine in the presence of l-metoprolol alone (6.34 +/- 0.74 vs 8.40 +/- 1.13). These results suggest that selective beta 1 blockade is effective in preventing halothane-epinephrine arrhythmias, but selective beta 2 blockade is not.

References

Sep 27, 1979·The New England Journal of Medicine·J Koch-Weser
Feb 1, 1990·Anesthesiology·J L Atlee, Z J Bosnjak
Apr 25, 1986·The American Journal of Cardiology·G Stene-LarsenR Fin
Apr 1, 1984·Physiological Reviews·G L StilesR J Lefkowitz
May 1, 1983·Journal of Cardiovascular Pharmacology·A J BilskiJ L Wale
Apr 1, 1983·Clinical Pharmacology and Therapeutics·J E BrownD G Shand

Citations

Jul 3, 1999·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·S TakahashiH Toyooka
Jan 1, 2003·Journal of Toxicology. Clinical Toxicology·Lewis S Nelson
Jul 12, 1995·Annals of the New York Academy of Sciences·Y HayashiI Yoshiya

Related Concepts

ICI 118551, hydrochloride
Adrenergic beta-Antagonists
Metazoa
Cardiac Arrhythmia
Diastolic Blood Pressure
Canis familiaris
Dose-Response Relationship, Drug
Epinephrine Acetate
Premature Cardiac Complex
Narcotan

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.